Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
12/2003
12/17/2003CN1131209C Alkyl dihalogenated phenyl-substituted ketoenols useful as. pesticides and herbicides
12/17/2003CN1131202C Calcium receptor-active compounds
12/16/2003US6664417 Contacting a molar excess of an aqueous solution of formaldehyde, gaseous formaldehyde or trioxane in a solvent with succinic anhydride, or mono or di-lower alkyl ester of of succinic acid in presence of metal oxide catalyst
12/16/2003US6664402 Continuous hydrogenation process
12/16/2003US6664259 Il-8 receptor antagonists
12/16/2003US6664258 Spirocyclic dopamine receptor subtype ligands
12/11/2003WO2003101932A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/11/2003WO2003101916A1 Method of substituent introduction through halogen-metal exchange reaction
12/11/2003WO2003101442A1 Peptide deformylase inhibitors
12/11/2003WO2003048145A3 Method for preparing an aminobenzofuran compound
12/11/2003WO2003048144A3 Method for monosulphonylation of an aminobenzofuran compound
12/11/2003WO2003027090A3 Bicyclic heterocycles as rxr ligands
12/11/2003WO2002100802A3 Fluorous triphase and other multiphase systems
12/11/2003WO2002048165A8 Antiviral agents for treatment of flaviviridae infections
12/11/2003US20030229234 Hydrophilic polymers; bonding strength, chemical resistance
12/11/2003US20030229132 Small molecule modulators of apoptosis
12/11/2003US20030229127 Heterocyclic sulfonamide inhibitors of beta amyloid production
12/11/2003US20030229121 Antihistamines, antiallergens, skin disorders, antiinflammatory agents
12/11/2003US20030229073 Tricyclic compounds and method of treating herpes virus
12/11/2003US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance
12/11/2003US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections
12/11/2003US20030228573 Contacting test compound with Gag283 and determining its ability to bind to the apical cleft near the C-terminal domain; use in treatment of Acquired Immunodeficiency Syndrome (AIDS)
12/11/2003CA2484451A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/10/2003EP1369419A1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
12/10/2003EP1369410A1 Process for the stereoselective reduction of derivatives of 4-aryl-4-oxobutyric acid
12/10/2003EP1368344A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)
12/10/2003EP1368333A1 Production of 5-methylbutyrolactone from levulinic acid
12/10/2003EP1368330A1 Process for the preparation of citalopram
12/10/2003EP1368329A1 Process for producing ascorbic acid in the presence of a sulfit
12/10/2003EP1368325A1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP1368306A1 Novel 1,2-diphenylethene derivatives for treatment of immune diseases
12/10/2003EP1368305A1 7, 9-substituted tetracycline compounds
12/10/2003EP1368299A2 Substituted c-cyclohexylmethylamine derivatives
12/10/2003EP1284263B1 Derivatives of p- hydroxy phenyl propionic acid as antiproliferative agents
12/10/2003EP1222181B1 Method for preparing a benzofuran or benzothiophene compound
12/10/2003EP1200393B1 Oxime amides and hydrazone amides having fungicidal activity
12/10/2003EP1123270B1 Preparation of amines
12/10/2003EP1058687B1 Nucleosides
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS
12/10/2003CN1460677A Method for preparing monochlorophthalic anhydride by means of chloration of phthalic anhydride
12/10/2003CN1130362C Nucleosides analogues, such as antivirals including inhititors of retroviral reverse transcriptase and DNA polymerase of heaptitis B virus (HBV)
12/10/2003CN1130266C Method for preparing monolithic oxidation catalysts and their use in gas phase oxidation of carbohydrates
12/09/2003US6660873 Method for the preparation of citalopram
12/09/2003US6660769 The presence of a substituted amine functional group in the C-3 position of 2,2-dialkyl-1,4-butyrolactones leads to a greater enhancement in GABA effects
12/09/2003US6660756 Protease inhibitors; sexual disorders
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/04/2003WO2003100081A2 Biologically active maleamic acid derivatives with labile amide bonds
12/04/2003WO2003099905A1 Method for producing polytetrahydrofurane with low colour indices
12/04/2003WO2003099803A1 Furancarboxamides
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF
12/04/2003WO2003099759A1 Preparation and application of transhintotalphenolic acid
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003WO2003089420A3 Recovery and purification of anhydro sugar alcohols from a vapor stream
12/04/2003WO2003089125A3 Hydrogenation catalyst, preparation thereof, and method for the preparation of gamma-butyrolactone from maleic anhydride using the catalyst
12/04/2003WO2003059875A3 DERIVATIVES OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATMENT OF DISEASES RESPONDING TO PPARα ACTIVATION
12/04/2003WO2003057169A3 4-dedimethylamino tetracycline compounds
12/04/2003WO2003051860A3 Substituted 2-phenyl benzofurans as estrogenic agents
12/04/2003WO2003034989A3 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
12/04/2003WO2003024946A3 Oxamate derivatives containing a variously substituted nitrogen heterocycle
12/04/2003WO2003018568A3 Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
12/04/2003US20030225289 Optical isomers of tricyclic amino alcohol derivatives including 2-(N-(2-(9H-carbazol-2-yloxy)ethyl))amino-1-((3-methylsulfonylamino)- phenyl)ethanol; reduction of a 2-bromo-1-(3-nitrophenyl)ethanone, epoxidation; aminosulfonation
12/04/2003US20030225285 Oxidizing a protected aminoalcohol to a chiral protected aminoaldehyde and diastereoselectively forming the aminoepoxide from said aminoaldehyde with an organometallic methylene-adding reagent in an appropriate solvent
12/04/2003US20030225283 2-Substituted phenyl,3-polar ring,N-heroaromatic propion-amides, e.g., 1-(2-(3,4-Dichlorophenyl)-3-(tetrahydro-furan-2-yl)-propionyl)-3- methylurea; antidiabetic agents; increase the flux of glucose metabolism in beta-cells and hepatocytes
12/04/2003US20030225282 Enantioselective process for preparing arylated lactones and derivatives
12/04/2003US20030225274 Ketone transfer hydrogenation of stereoisomerically enriched 3-heteroaryl-3-oxocarboxylic esters by reducing 3-heteroaryl-3-hydroxycarboxylic esters in the presence of a ruthenium-containing catalyst, an amine and formic acid and/or formates
12/04/2003US20030225158 Compounds that modulate PPAR activity and methods for their preparation
12/04/2003US20030225100 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same
12/04/2003US20030225087 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
12/04/2003US20030225084 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others.
12/04/2003US20030225080 Treating a disorder responsive to the blockade of sodium channels
12/04/2003US20030225077 Naphthylamines used to chronic inflammatory diseases.
12/04/2003US20030225074 E.g., 2-((4'-Methoxy(1,1'-biphenyl)-4-yl)sulfonyl)amino-4-hydroxy-5-((2 -thiazolyl)thio)-pentanoic Acid
12/04/2003US20030225071 N-heterocyclic amides and carbamates
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003US20030225053 N-arylcarboxamides of fused ring systems including naphthalenes, benzothiophenes, benzofurans and indoles
12/04/2003US20030224483 Control of gene expression in eukaryotic cells
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/03/2003EP1367111A1 Photochromic material
12/03/2003EP1366055A2 Antiviral agents for treatment of flaviviridae infections
12/03/2003EP1366034A1 Preparation of phthalanes
12/03/2003EP1366033A1 Chemical compounds
12/03/2003EP1366024A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
12/03/2003EP1366016A2 Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
12/03/2003EP1246811B1 Methods for resolving racemic mixtures of 5-substituted 4-hydroxy-2-furanones
12/03/2003EP1075483B1 Hygromycin a derivatives
12/03/2003CN1459448A Preparation method of red sageroot total phenolic acid and its use
12/03/2003CN1129593C Method for prepn of citalopram
12/03/2003CN1129592C Method for preparation of citalopram
12/03/2003CN1129591C O-substituted hydroxycumaranone derivatives as antitumor and antimetastatic agents
12/03/2003CN1129590C Reference compound for use in analysis of levosimendan batches
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/03/2003CN1129572C Tanshinpolyphenolic salt mixture and preparation and application thereof
12/03/2003CN1129567C Process for preparation of cyclopropylacetylene derivatives
12/02/2003US6657093 Preparation of substituted aromatic compounds
12/02/2003US6657085 By reacting nitro compounds with hydrazine at elevated temperature in the presence of an aqueous base; intermediates in the preparation of herbicides of the isobenzofuranone type
12/02/2003US6657070 Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
12/02/2003US6657068 Liquid phase oxidation of halogenated ortho-xylenes
1 ... 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 ... 472